Literature DB >> 21956716

Different clinical and neuropathologic phenotypes of familial ALS with A315E TARDBP mutation.

Y Fujita1, M Ikeda, T Yanagisawa, Y Senoo, K Okamoto.   

Abstract

OBJECTIVE: To present the relationship between TARDBP gene mutation and clinicopathologic findings of a Japanese pedigree affected by familial amyotrophic lateral sclerosis (FALS).
METHODS: The clinical, genetic, and neuropathologic characteristics of 4 members of a Japanese pedigree affected by FALS were examined.
RESULTS: All the patients showed motor neuron signs, and 2 of them also had parkinsonism. We identified A315E TARDBP mutation in one patient per clinical disease type and found loss of anterior horn cells, Bunina bodies, and phosphorylated TDP-43-positive neuronal and glial cytoplasmic inclusions in both the patients. However, the patient with only motor neuron signs had degeneration of the posterior column and spinocerebellar tracts as well as neuronal loss of the Clarke column, and the patient with both motor neuron signs and parkinsonism had severe nigral degeneration without Lewy pathology.
CONCLUSION: The clinical and neuropathologic phenotypes of FALS may differ even with the same mutation of TARDBP, encoding TDP-43. Isolated TDP-43 pathology can produce ALS-plus syndrome.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21956716     DOI: 10.1212/WNL.0b013e318232ab87

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  12 in total

1.  TARDBP mutations in Parkinson's disease.

Authors:  Sruti Rayaprolu; Shinsuke Fujioka; Sharleen Traynor; Alexandra I Soto-Ortolaza; Leonard Petrucelli; Dennis W Dickson; Rosa Rademakers; Kevin B Boylan; Neill R Graff-Radford; Ryan J Uitti; Zbigniew K Wszolek; Owen A Ross
Journal:  Parkinsonism Relat Disord       Date:  2012-12-08       Impact factor: 4.891

2.  An ALS-mutant TDP-43 neurotoxic peptide adopts an anti-parallel β-structure and induces TDP-43 redistribution.

Authors:  Li Zhu; Meng Xu; Mengxue Yang; Yanlian Yang; Yang Li; Jianwen Deng; Linhao Ruan; Jianghong Liu; Sidan Du; Xuehui Liu; Wei Feng; Kazuo Fushimi; Eileen H Bigio; Marsel Mesulam; Chen Wang; Jane Y Wu
Journal:  Hum Mol Genet       Date:  2014-08-11       Impact factor: 6.150

Review 3.  Parkinsonism, movement disorders and genetics in frontotemporal dementia.

Authors:  José Fidel Baizabal-Carvallo; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2016-02-19       Impact factor: 42.937

4.  Specific RNA interactions promote TDP-43 multivalent phase separation and maintain liquid properties.

Authors:  Zachary R Grese; Alliny Cs Bastos; Lohany D Mamede; Rachel L French; Timothy M Miller; Yuna M Ayala
Journal:  EMBO Rep       Date:  2021-11-17       Impact factor: 8.807

5.  Accelerated disease onset with stabilized familial amyotrophic lateral sclerosis (ALS)-linked mutant TDP-43 proteins.

Authors:  Shoji Watanabe; Kumi Kaneko; Koji Yamanaka
Journal:  J Biol Chem       Date:  2012-12-12       Impact factor: 5.157

6.  Drosophila lines with mutant and wild type human TDP-43 replacing the endogenous gene reveals phosphorylation and ubiquitination in mutant lines in the absence of viability or lifespan defects.

Authors:  Jer-Cherng Chang; David B Morton
Journal:  PLoS One       Date:  2017-07-07       Impact factor: 3.240

7.  Nuclear TAR DNA-binding protein 43: A new target for amyotrophic lateral sclerosis treatment.

Authors:  Mei Zheng; Yujie Shi; Dongsheng Fan
Journal:  Neural Regen Res       Date:  2013-12-15       Impact factor: 5.135

8.  Structural analysis of disease-related TDP-43 D169G mutation: linking enhanced stability and caspase cleavage efficiency to protein accumulation.

Authors:  Chien-Hao Chiang; Cédric Grauffel; Lien-Szu Wu; Pan-Hsien Kuo; Lyudmila G Doudeva; Carmay Lim; Che-Kun James Shen; Hanna S Yuan
Journal:  Sci Rep       Date:  2016-02-17       Impact factor: 4.379

Review 9.  The Genetics of Monogenic Frontotemporal Dementia.

Authors:  Leonel T Takada
Journal:  Dement Neuropsychol       Date:  2015 Jul-Sep

Review 10.  Genetic mutations in RNA-binding proteins and their roles in ALS.

Authors:  Katannya Kapeli; Fernando J Martinez; Gene W Yeo
Journal:  Hum Genet       Date:  2017-07-31       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.